Published in Compr Psychiatry on June 10, 1993
Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci (2006) 1.23
Sleep quality deteriorates over a binge--abstinence cycle in chronic smoked cocaine users. Psychopharmacology (Berl) (2005) 1.17
Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addict Behav (2008) 1.06
Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria. Drug Alcohol Depend (2013) 1.00
Attentional deficits in cocaine-dependent patients: converging behavioral and electrophysiological evidence. Psychiatry Res (2008) 0.95
Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial. J Dual Diagn (2009) 0.92
Childhood ADHD symptoms are associated with lifetime and current illicit substance-use disorders and in-site health risk behaviors in a representative sample of Latino prison inmates. J Atten Disord (2012) 0.91
A behavioral treatment for opioid-dependent patients with antisocial personality. J Subst Abuse Treat (2007) 0.89
Associations between attention deficit hyperactivity disorder symptom domains and DSM-IV lifetime substance dependence. Am J Addict (2013) 0.88
Treatment strategies for co-occurring ADHD and substance use disorders. Am J Addict (2007) 0.87
Diagnosing and treating attention-deficit/hyperactivity disorder in adults. World Psychiatry (2008) 0.87
Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. Drug Alcohol Depend (2013) 0.86
Trajectories of Substance Use Disorders in Youth: Identifying and Predicting Group Memberships. J Child Adolesc Subst Abuse (2010) 0.84
Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry (2015) 0.83
Correlates of alcohol use in adults with ADHD and comorbid alcohol use disorders: exploratory analysis of a placebo-controlled trial of atomoxetine. Curr Med Res Opin (2011) 0.81
Treatment attendance among homeless youth: the impact of childhood abuse and prior suicide attempts. Subst Abus (2008) 0.80
Substance-use disorders in adolescents and adults with ADHD: focus on treatment. Neuropsychiatry (London) (2012) 0.80
A systematic review of global publication trends regarding long-term outcomes of ADHD. Front Psychiatry (2012) 0.79
The utility of attention-deficit/hyperactivity disorder screening instruments in individuals seeking treatment for substance use disorders. J Clin Psychiatry (2012) 0.79
Familial risk analysis of the association between attention-deficit/hyperactivity disorder and psychoactive substance use disorder in female adolescents: a controlled study. J Child Psychol Psychiatry (2009) 0.79
Safety of atomoxetine in combination with intravenous cocaine in cocaine-experienced participants. J Addict Med (2012) 0.79
Homovanillic acid (HVA) plasma levels inversely correlate with attention deficit-hyperactivity and childhood neglect measures in addicted patients. J Neural Transm (Vienna) (2007) 0.79
Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial. BMC Psychiatry (2013) 0.78
An Open Trial of Sustained Release Bupropion for Attention-Deficit/Hyperactivity Disorder in Adults with ADHD plus Substance Use Disorders. J ADHD Relat Disord (2010) 0.77
Methylphenidate transdermal system in adults with past stimulant misuse: an open-label trial. J Atten Disord (2010) 0.76
Psychotherapy of adults with comorbid attention-deficit/hyperactivity disorder and psychoactive substance use disorder. J Psychother Pract Res (2001) 0.75
Adult attention-deficit/hyperactivity disorder: Associations between subtype and lifetime substance use - a clinical study. F1000Res (2015) 0.75
ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders. J Atten Disord (2016) 0.75
Childhood Symptoms of ADHD and Impulsivity in Abstinent Heroin Users. J Dual Diagn (2015) 0.75
Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us? Harv Rev Psychiatry (2017) 0.75
Co-occurring Attention Deficit Hyperactivity Disorder symptoms in adults affected by heroin dependence: Patients characteristics and treatment needs. Psychiatry Res (2017) 0.75
A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions. Drug Alcohol Depend (2000) 4.92
Familial transmission of substance use disorders. Arch Gen Psychiatry (1998) 4.57
One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects. Arch Gen Psychiatry (1994) 3.20
Internal validity of Project MATCH treatments: discriminability and integrity. J Consult Clin Psychol (1998) 2.56
Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention. J Gen Intern Med (2000) 2.45
A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. Am J Med (1998) 2.37
Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement. Arch Gen Psychiatry (2001) 2.29
Functional magnetic resonance imaging of cocaine craving. Am J Psychiatry (2001) 2.14
One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment. Addiction (2000) 1.93
Gender-related differences in the characteristics of problem gamblers using a gambling helpline. Am J Psychiatry (2001) 1.93
Psychopathology as a predictor of treatment outcome in alcoholics. Arch Gen Psychiatry (1987) 1.91
Three methods of opioid detoxification in a primary care setting. A randomized trial. Ann Intern Med (1997) 1.87
Sensitivity of psychiatric diagnosis based on the best estimate procedure. Am J Psychiatry (1992) 1.87
Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry (2000) 1.82
Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch Gen Psychiatry (1994) 1.81
Validity of the SCID in substance abuse patients. Addiction (1996) 1.74
Concurrent validity of the addiction severity index. J Nerv Ment Dis (1983) 1.68
One-year follow-up status of treatment-seeking cocaine abusers. Psychopathology and dependence severity as predictors of outcome. J Nerv Ment Dis (1993) 1.66
Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts. Addiction (2000) 1.66
Multiple jeopardy: risk and protective factors among addicted mothers' offspring. Dev Psychopathol (1998) 1.65
Untreated opiate addicts. How do they differ from those seeking treatment? Arch Gen Psychiatry (1985) 1.63
Illegal behaviors in problem gambling: analysis of data from a gambling helpline. J Am Acad Psychiatry Law (2000) 1.62
Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study. Arch Gen Psychiatry (1986) 1.62
Comorbid psychiatric diagnosis predicts three-year outcomes in alcoholics: a posttreatment natural history study. J Stud Alcohol (1996) 1.54
Gender differences in cocaine use and treatment response. J Subst Abuse Treat (1993) 1.50
Contribution of the therapeutic alliance to outcome in active versus control psychotherapies. J Consult Clin Psychol (1997) 1.42
Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch Gen Psychiatry (1982) 1.42
Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome. Arch Gen Psychiatry (1982) 1.42
Gender differences in treatment-seeking cocaine abusers--implications for treatment and prognosis. Am J Addict (1999) 1.41
Alcoholism in treatment-seeking cocaine abusers: clinical and prognostic significance. J Stud Alcohol (1993) 1.40
Implementing treatment and protecting the validity of the independent variable in treatment matching studies. J Stud Alcohol Suppl (1994) 1.40
Ambulatory opiate detoxification and primary care: a role for the primary care physician. J Gen Intern Med (1992) 1.39
Contrast of treatment-seeking and untreated cocaine abusers. Arch Gen Psychiatry (1992) 1.37
Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost. Am J Psychiatry (1999) 1.34
Training therapists to perform interpersonal psychotherapy in clinical trials. Compr Psychiatry (1986) 1.32
Motivational interviewing with psychiatrically ill substance abusing patients. Am J Addict (2000) 1.23
Ethnic and gender differences among opiate addicts. Int J Addict (1985) 1.22
Pathological gambling. JAMA (2001) 1.21
Personality, temperament, and character dimensions and the DSM-IV personality disorders in substance abusers. J Abnorm Psychol (1997) 1.20
A comparative trial of psychotherapies for ambulatory cocaine abusers: relapse prevention and interpersonal psychotherapy. Am J Drug Alcohol Abuse (1991) 1.20
Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry (1989) 1.19
Sensation seeking, substance abuse, and psychopathology in treatment-seeking and community cocaine abusers. J Consult Clin Psychol (1994) 1.17
A 2.5-year follow-up of cocaine use among treated opioid addicts. Have our treatments helped? Arch Gen Psychiatry (1987) 1.16
HIV infection and cocaine use in methadone maintained and untreated intravenous drug users. Drug Alcohol Depend (1994) 1.15
Psychotherapies for adolescent substance abusers: a pilot study. J Nerv Ment Dis (1998) 1.14
A sibling study of sensation seeking and opiate addiction. J Nerv Ment Dis (1994) 1.13
Proposed changes in DSM-III substance use disorders: description and rationale. Am J Psychiatry (1986) 1.13
Validity of the longitudinal, expert, all data procedure for psychiatric diagnosis in patients with psychoactive substance use disorders. Drug Alcohol Depend (1997) 1.12
A 2.5-year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts. Arch Gen Psychiatry (1986) 1.08
Personality disorders in opiate addicts show prognostic specificity. J Subst Abuse Treat (1989) 1.06
Experience of a "slip" among alcoholics treated with naltrexone or placebo. Am J Psychiatry (1996) 1.06
Subtypes of cocaine abusers: support for a type A-type B distinction. J Consult Clin Psychol (1995) 1.04
Treatment for opioid dependence: quality and access. JAMA (2000) 1.03
Substance-use disorders in DSM-III-R. Evidence for the dependence syndrome across different psychoactive substances. Br J Psychiatry (1987) 1.03
Primary care-based ambulatory opioid detoxification: the results of a clinical trial. J Gen Intern Med (1995) 1.01
Antecedents and consequences of cocaine abuse among opioid addicts. A 2.5-year follow-up. J Nerv Ment Dis (1988) 1.00
'Research' versus 'real-world' patients: representativeness of participants in clinical trials of treatments for cocaine dependence. Drug Alcohol Depend (1999) 1.00
Research diagnostic criteria subtypes of depression. Their role as predictors of differential response to psychotherapy and drug treatment. Arch Gen Psychiatry (1980) 0.99
Interpersonal psychotherapy adapted for ambulatory cocaine abusers. Am J Drug Alcohol Abuse (1985) 0.99
Blind man's bluff: effectiveness and significance of psychotherapy and pharmacotherapy blinding procedures in a clinical trial. J Consult Clin Psychol (1994) 0.97
Battered wives: barriers to identification and treatment. Am J Orthopsychiatry (1978) 0.96
Gender differences among opioid abusers: pathways to disorder and profiles of psychopathology. Drug Alcohol Depend (1996) 0.96
Co-occurrence of Axis I and Axis II disorders in substance abusers. Acta Psychiatr Scand (2000) 0.95
Cocaine abuse among opioid addicts: demographic and diagnostic factors in treatment. Am J Drug Alcohol Abuse (1986) 0.95
Reliability of personality disorder symptoms and personality traits in substance-dependent inpatients. J Abnorm Psychol (2001) 0.95
Predictors of outcome in treatment of opiate addicts: evidence for the multidimensional nature of addicts' problems. Compr Psychiatry (1983) 0.94
Ascertaining psychiatric diagnoses with the family history method in a substance abuse population. J Psychiatr Res (1992) 0.94
Parental psychopathology and disorders in offspring. A study of relatives of drug abusers. J Nerv Ment Dis (1993) 0.91
Multidimensional subtypes and treatment outcome in first-time DWI offenders. Addict Behav (2000) 0.91
Training psychotherapists to participate in psychotherapy outcome studies. Am J Psychiatry (1982) 0.91
Short-term interpersonal psychotherapy in methadone-maintained opiate addicts. Arch Gen Psychiatry (1983) 0.91
Role of manual-guided training in the conduct and efficacy of interpersonal psychotherapy for depression. J Consult Clin Psychol (1988) 0.90
Validity of psychiatric diagnoses in patients with substance use disorders: is the interview more important than the interviewer? Compr Psychiatry (1995) 0.90
Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts. Am J Drug Alcohol Abuse (1985) 0.90
Therapist competence and patient outcome in interpersonal psychotherapy of depression. J Consult Clin Psychol (1988) 0.89
Vulnerability to drug abuse among opioid addicts' siblings: individual, familial, and peer influences. Compr Psychiatry (1992) 0.89
Psychiatric comorbidity in white and African-American cocaine addicts seeking substance abuse treatment. Hosp Community Psychiatry (1994) 0.89
Suicidality among opioid addicts: 2.5 year follow-up. Am J Drug Alcohol Abuse (1988) 0.89
Axis I and Axis II disorders in alcoholics and drug addicts: fact or artifact? J Stud Alcohol (2000) 0.89
Coherence of the dependence syndrome in cocaine users. Br J Addict (1991) 0.89
Success and failure at outpatient opioid detoxification. Evaluating the process of clonidine- and methadone-assisted withdrawal. J Nerv Ment Dis (1985) 0.89
Generalizability of the type A/type B distinction across different psychoactive substances. Am J Drug Alcohol Abuse (1996) 0.89
On beyond urine: clinically useful assessment instruments in the treatment of drug dependence. Behav Res Ther (2002) 0.89
Pathways to opiate addiction: an evaluation of differing antecedents. Br J Psychiatry (1982) 0.89
Should tolerance and withdrawal be required for substance dependence disorders? Drug Alcohol Depend (1994) 0.88
Personality and substance use disorders as predictors of criminality. Compr Psychiatry (2000) 0.88
Do psychotherapy and pharmacotherapy for depression conflict? Empirical evidence from a clinical trial. Arch Gen Psychiatry (1981) 0.88
Imipramine as treatment for depression in addicts. Arch Gen Psychiatry (1983) 0.87
Relapse prevention strategies for the treatment of cocaine abuse. Am J Drug Alcohol Abuse (1991) 0.86
Vulnerability to substance abuse and psychopathology among siblings of opioid abusers. J Nerv Ment Dis (1992) 0.86
Personality disorder and dimension differences between type A and type B substance abusers. J Pers Disord (1998) 0.85
Longitudinal, expert, all data procedure for psychiatric diagnosis in patients with psychoactive substance use disorders. J Nerv Ment Dis (1994) 0.85
A 2.5 year follow-up of treatment retention and reentry among opioid addicts. J Subst Abuse Treat (1986) 0.85
Differential symptom reduction in depressed cocaine abusers treated with psychotherapy and pharmacotherapy. J Nerv Ment Dis (1995) 0.85
Psychotherapy with depressed outpatients: patient and process variables as predictors of outcome. Br J Psychiatry (1981) 0.85
History of childhood hyperactivity in a clinic population of opiate addicts. J Nerv Ment Dis (1982) 0.84
DSM-III personality disorders in opiate addicts. Compr Psychiatry (1983) 0.83
Substance misuse and comorbid psychopathology in a high-risk group: a study of siblings of cocaine misusers. Int J Addict (1993) 0.83
A preliminary investigation of the management of alcohol dependence with naltrexone by primary care providers. Am J Med (1997) 0.83